Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
Dubinsky
Richard M
RM
D019274:Botulinum Toxins, Type A / Q000009:adverse effects* / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000150:complications; D002648:Child; D006801:Humans; D015201:Meta-Analysis as Topic; D009128:Muscle Spasticity / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012640:Seizures / Q000139:chemically induced
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A